Table 1.
Patient characteristics.
Variable | Patient group (N = 27) | Control group (N = 19) |
---|---|---|
Age [Years, Mean ± SD] | 70.2 ± 13.4 | 67.2 ± 9.3 |
Sex [as % female] | 40.7 | 31.6 |
Co-morbidities | ||
Hypertension [n (%)] | 23 (85.19) | 15 (78.95) |
Diabetes mellitus [n (%)] | 10 (37.04) | 8 (42.11) |
Stroke characteristics | ||
Etiology | ||
Large-artery atherosclerosis [n (%)] | 3 (11.11) | NA$ |
Cardio embolism [n (%)] | 9 (33.33) | NA$ |
Stroke of other determined etiology [n (%)] | 5 (18.52) | NA$ |
Stroke of undetermined etiology [n (%)] | 10 (37.04) | NA$ |
1. MRI Stroke Size* [ml3, Median (IQR)] | 2,88 (4.83) | NA$ |
Initial NIHSS [Median (IQR)] | 11 (7) | NA$ |
NIHSS at discharge [Median (IQR)] | 4 (7.5) | |
Infarct side [n (%) left sided infarcts] | 19 (70.37) | NA$ |
Treatment [n (%)] | 19 (70.37) | NA$ |
Systemic Thrombolysis [n (%)]& | 17 (89.47) | NA$ |
Mechanical Thrombectomy [n (%)]& | 10 (52.63) | NA$ |
Combined Treatment [n (%)]& | 8 (42.11) | NA$ |
The numbers of systemic thrombolysis and mechanical thrombectomies are the total number of patients receiving the treatments and include patients receiving a combination of both.
NA, Not applicable.
Stroke size could be determined in 7 out of the 27 patients.